STOCK TITAN

ESAB (NYSE: ESAB) director receives RSUs, deferred units and stock options grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

ESAB Corp director Didier P. Teirlinck received new equity awards as part of his compensation. On May 8, 2026, he was granted 406 restricted stock units and 407 deferred stock units, each representing a contingent right to receive one share of ESAB common stock.

The restricted and deferred stock units vest in a single installment on June 1, 2027, with the deferred units to be settled in ESAB common stock after his separation from the company. He also received stock options for 2,647 shares at an exercise price of $100.94 per share, which vested and became exercisable on the grant date and expire on May 7, 2033.

Positive

  • None.

Negative

  • None.
Insider Teirlinck Didier P
Role null
Type Security Shares Price Value
Grant/Award Stock Option (right to buy) 2,647 $0.00 --
Grant/Award Deferred Stock Units 407 $0.00 --
Grant/Award Restricted Stock Units 406 $0.00 --
Holdings After Transaction: Stock Option (right to buy) — 2,647 shares (Direct, null); Deferred Stock Units — 407 shares (Direct, null); Restricted Stock Units — 406 shares (Direct, null)
Footnotes (1)
  1. These stock options vested and became exercisable on the grant date. Each deferred stock unit represents a contingent right to receive one share of ESAB common stock. These deferred stock units vest in a single installment on June 1, 2027. Once vested, the units will be settled in ESAB common stock after the director's separation from the Company. Each restricted stock unit represents a contingent right to receive one share of ESAB common stock. These restricted stock units vest in a single installment on June 1, 2027.
Restricted stock units granted 406 units Granted to director Didier P. Teirlinck on May 8, 2026
Deferred stock units granted 407 units Granted on May 8, 2026; vest June 1, 2027
Stock options granted 2,647 options Director grant on May 8, 2026
Option exercise price $100.94 per share Stock Option (right to buy) for 2,647 shares
RSU vesting date June 1, 2027 Restricted stock units vest in single installment
DSU vesting date June 1, 2027 Deferred stock units vest in single installment
Option expiration date May 7, 2033 Expiration of 2,647 stock options
Restricted Stock Units financial
"security_title: Restricted Stock Units; each unit is a contingent right to stock"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Deferred Stock Units financial
"security_title: Deferred Stock Units; settled in ESAB stock after separation"
Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy) with a $100.94 exercise price"
contingent right to receive one share financial
"Each restricted or deferred stock unit represents a contingent right to receive one share"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Teirlinck Didier P

(Last)(First)(Middle)
909 ROSE AVE, 8TH FLOOR

(Street)
NORTH BETHESDA MARYLAND 20852

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
ESAB Corp [ ESAB ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/08/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)$100.9405/08/2026A2,64705/08/2026(1)05/07/2033Common stock, par value $0.0012,647$02,647D
Deferred Stock Units(2)05/08/2026A407 (3) (3)Common stock, par value $0.001407$0407D
Restricted Stock Units(4)05/08/2026A40606/01/2027(5)06/01/2027Common stock, par value $0.001406$0406D
Explanation of Responses:
1. These stock options vested and became exercisable on the grant date.
2. Each deferred stock unit represents a contingent right to receive one share of ESAB common stock.
3. These deferred stock units vest in a single installment on June 1, 2027. Once vested, the units will be settled in ESAB common stock after the director's separation from the Company.
4. Each restricted stock unit represents a contingent right to receive one share of ESAB common stock.
5. These restricted stock units vest in a single installment on June 1, 2027.
Remarks:
/s/ Curtis E. Jewell, Attorney-in-Fact05/12/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)